BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+20.63%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$600M
AUM Growth
+$600M
(+5%)
Cap. Flow
-$66.1M
Cap. Flow
% of AUM
-11.01%
Top 10 Holdings %
Top 10 Hldgs %
85.23%
Holding
31
New
4
Increased
3
Reduced
10
Closed
3
Top Buys
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$13.3M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$5.62M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$4.39M |
| 4 |
TRVN
Trevena, Inc.
TRVN
|
$2.75M |
| 5 |
VXRT
Vaxart
VXRT
|
$2.66M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$35.6M |
| 2 |
Cytokinetics
CYTK
|
$21.5M |
| 3 |
Rigel Pharmaceuticals
RIGL
|
$20.8M |
| 4 |
Xencor
XNCR
|
$7.5M |
| 5 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$3.39M |
Sector Composition
| 1 | Healthcare | 77.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agios Pharmaceuticals
AGIO
$2.19B
| – | – | -196,996 | Closed | -$47K |
|
27
Amgen
AMGN
$155B
| – | – | 0 | – | – |
|
|
28
Xencor
XNCR
$580M
| – | – | -820,000 | Closed | -$7.5M |
|
|
KIN
29
DELISTED
Kindred Biosciences, Inc.
KIN
| – | – | -51,788 | Closed | -$577K |
|